LDL Cholesterol and the Development of Stroke Subtypes and Coronary Heart Disease in a General Japanese Population The Hisayama Study

被引:168
作者
Imamura, Tsuyoshi [1 ]
Doi, Yasufumi [2 ]
Arima, Hisatomi
Yonemoto, Koji
Hata, Jun
Kubo, Michiaki
Tanizaki, Yumihiro
Ibayashi, Setsuro [2 ]
Iida, Mitsuo [2 ]
Kiyohara, Yutaka [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Environm Med, Higashi Ku, Fukuoka 8128582, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 8128582, Japan
关键词
epidemiology; cholesterol; lipoproteins; risk factors; DENSITY-LIPOPROTEIN CHOLESTEROL; SERUM TOTAL CHOLESTEROL; CARDIOVASCULAR-DISEASE; RISK-FACTORS; ATHEROSCLEROSIS RISK; METABOLIC SYNDROME; ISCHEMIC-STROKE; MORTALITY; PLASMA; METAANALYSIS;
D O I
10.1161/STROKEAHA.108.529537
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Although the relation between serum LDL cholesterol level and coronary heart disease (CHD) is well established, its relation with stroke subtypes is less clear. Methods-A total of 2351 inhabitants age >= 40 years in a Japanese community were followed up for 19 years. Results-During follow-up, 271 subjects developed stroke and 144 developed CHD. Whereas the age- and sex-adjusted incidences of CHD significantly increased with increasing LDL cholesterol levels (P for trend <0.001), the associations between LDL cholesterol level and the incidences of ischemic or hemorrhagic stroke were not significant. The age- and sex-adjusted incidences of atherothrombotic infarctions (ATIs) and lacunar infarctions (LIs) significantly increased with increasing LDL cholesterol level (P for trend=0.03 for ATIs and=0.02 for LIs), but no such association was observed for cardioembolic infarction. After multivariate adjustment, the positive associations of LDL cholesterol level with the risks of ATI and CHD remained significant (P for trend=0.02 for ATIs and=0.03 for CHD), whereas the association with LIs was not significant. The risk of ATI significantly increased in the fourth quartile of LDL cholesterol compared with the first quartile (multivariate-adjusted hazard ratio=2.84; 95% CI, 1.17 to 6.93). The multivariate-adjusted risks for developing nonembolic infarction (ATIs and LIs) and CHD were significantly elevated in the groups with elevated LDL cholesterol values with and without the metabolic syndrome. Conclusions-Our findings suggest that an elevated LDL cholesterol level is a significant risk factor for developing ATI as well as CHD, and these associations are independent of the metabolic syndrome. (Stroke. 2009; 40: 382-388.)
引用
收藏
页码:382 / 388
页数:7
相关论文
共 34 条
[1]   CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL [J].
ADAMS, HP ;
BENDIXEN, BH ;
KAPPELLE, LJ ;
BILLER, J ;
LOVE, BB ;
GORDON, DL ;
MARSH, EE ;
KASE, CS ;
WOLF, PA ;
BABIKIAN, VL ;
LICATAGEHR, EE ;
ALLEN, N ;
BRASS, LM ;
FAYAD, PB ;
PAVALKIS, FJ ;
WEINBERGER, JM ;
TUHRIM, S ;
RUDOLPH, SH ;
HOROWITZ, DR ;
BITTON, A ;
MOHR, JP ;
SACCO, RL ;
CLAVIJO, M ;
ROSENBAUM, DM ;
SPARR, SA ;
KATZ, P ;
KLONOWSKI, E ;
CULEBRAS, A ;
CAREY, G ;
MARTIR, NI ;
FICARRA, C ;
HOGAN, EL ;
CARTER, T ;
GURECKI, P ;
MUNTZ, BK ;
RAMIREZLASSEPAS, M ;
TULLOCH, JW ;
QUINONES, MR ;
MENDEZ, M ;
ZHANG, SM ;
ALA, T ;
JOHNSTON, KC ;
ANDERSON, DC ;
TARREL, RM ;
NANCE, MA ;
BUDLIE, SR ;
DIERICH, M ;
HELGASON, CM ;
HIER, DB ;
SHAPIRO, RA .
STROKE, 1993, 24 (01) :35-41
[2]   PLASMA-LIPOPROTEINS IN CORTICAL VERSUS LACUNAR INFARCTION [J].
ADAMS, RJ ;
CARROLL, RM ;
NICHOLS, FT ;
MCNAIR, N ;
FELDMAN, DS ;
FELDMAN, EB ;
THOMPSON, WO .
STROKE, 1989, 20 (04) :448-452
[3]   Blood lipids in brain infarction subtypes [J].
Amarenco, Pierre ;
Labreuche, Julien ;
Elbaz, Alexis ;
Touboul, Pierre-Jean ;
Driss, Fathi ;
Jaillard, Assia ;
Bruckert, Eric .
CEREBROVASCULAR DISEASES, 2006, 22 (2-3) :101-108
[4]  
[Anonymous], 1986, Arch Neurol, V43, P71
[5]   Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].
Baigent, C ;
Keech, A ;
Kearney, PM ;
Blackwell, L ;
Buck, G ;
Pollicino, C ;
Kirby, A ;
Sourjina, T ;
Peto, R ;
Collins, R ;
Simes, J .
LANCET, 2005, 366 (9493) :1267-1278
[6]   Effects of statins on stroke prevention in patients with and without coronary heart disease: A meta-analysis of randomized controlled trials [J].
Briel, M ;
Studer, M ;
Glass, TR ;
Bucher, HC .
AMERICAN JOURNAL OF MEDICINE, 2004, 117 (08) :596-606
[7]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[8]   Risk factors and segment-specific carotid arterial enlargement in the atherosclerosis risk in communities (ARIC) cohort [J].
Crouse, JR ;
Goldbourt, U ;
Evans, G ;
Pinsky, J ;
Sharrett, AR ;
Sorlie, P ;
Riley, W ;
Heiss, G .
STROKE, 1996, 27 (01) :69-75
[9]   LACUNAR STROKES AND INFARCTS - A REVIEW [J].
FISHER, CM .
NEUROLOGY, 1982, 32 (08) :871-876
[10]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499